Targeting the noncatalytic activity of GSK3β modulates neuronal excitability in medium spiny neurons via Nav1.6 interactions
British Journal of Pharmacology · 2026-08 · 183 (15) · 4344-4363
DOI: 10.1111/bph.70458 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 28.04.2026. Verfasst von Aditya K Singh und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: NAV1.6 Voltage-Gated Sodium Channel, Glycogen Synthase Kinase 3 beta, Medium Spiny Neurons, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMH NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Background and Purpose Kinases phosphorylate ion channels, but their noncatalytic roles via protein–protein interactions (PPI) are less understood. Here, we identified the peptidomimetic ZL141 to characterize the PPI between GSK3β and Nav1.6, revealing a noncatalytic role for GSK3β in regulating Nav1.6 currents and neuronal excitability. Experimental Approach To screen peptide inhibitors, the GSK3β/Nav1.6 C‐terminal tail (CTD) PPI was reconstituted using split‐luciferase complementation assay. Intrinsic fluorescence spectroscopy (IFS), surface plasmon resonance (SPR), kinase assays, and molecular docking were used to assess peptidomimetic binding and predict the PPI interface. ZL141's function was evaluated via patch‐clamp electrophysiology in heterologous cells and nucleus accumbens (NAc) medium spiny neurons (MSNs), along with in vivo GSK3β silencing. Key Results ZL141 disrupts GSK3β/Nav1.6 CTD complex formation without altering GSK3β's catalytic activity. AlphaFold modelling predicted the ZL141 binding site at the surface of the GSK3β/Nav1.6 CTD PPI interface. ZL141 has a micromolar affinity for GSK3β, suppresses Na + currents, and affects Nav1.6 activation and inactivation kinetics. In vivo, silencing GSK3β in the NAc mimics the inhibitory effects of ZL141 on MSN firing and occludes any further pharmacological activity of the compound. Conclusions and Implications These findings reveal a critical PPI role of GSK3β in transducing Nav1.6 function and contributing to MSN firing. Both GSK3β and Nav1.6 activities are dysregulated in neurological and neuropsychiatric disorders. Given that Nav1.6 hyperactivity is implicated in maladaptive reward signalling, PPI‐targeted modulation using compounds like ZL141 may offer a precision pharmacological strategy for treating psychiatric disorders such as bipolar disorder or schizophrenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, USA.
- IonTX Inc, Friendswood, Texas, USA.
- Department of Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.
- Advanced Technology Cores, Baylor College of Medicine, Houston, Texas, USA.
- GCC Center for 5 Advanced Microscopy and Image Informatics, Houston, Texas, USA.
- Department of Biostatistics and Data Science, University of Texas Medical Branch, Galveston, Texas, USA.
Förderung
- NIMH NIH HHS
- NIH HHS
- NIGMS NIH HHS
- Cancer Prevention and Research Institute of Texas (CPRIT)
- Integrated Microscopy Core at Baylor College of Medicine
- NIEHS NIH HHS
- UTMB Technology Commercialization Program
- John S. Dunn Gulf Coast Consortium for Chemical Genomics
Zitieren
APA
Singh, A. K., Haghighijoo, Z., Gurtu, A., Dvorak, N. M., Baumgartner, T. J., Goode, N. A., Singh, J., Bernabucci, M., Szafran, A. T., Bolt, M. J., Mancini, M. A., Dvorak, N. M., Lijffijt, M., Liu, Z., Xue, Y., Thomas, A. K., Villasante-Tezanos, A., Krishnan, B., Zhou, J., & Laezza, F. (2026). Targeting the noncatalytic activity of GSK3β modulates neuronal excitability in medium spiny neurons via Nav1.6 interactions. British Journal of Pharmacology, 183(15), 4344-4363. https://doi.org/10.1111/bph.70458
Vancouver
Singh AK, Haghighijoo Z, Gurtu A, Dvorak NM, Baumgartner TJ, Goode NA, et al. Targeting the noncatalytic activity of GSK3β modulates neuronal excitability in medium spiny neurons via Nav1.6 interactions. British Journal of Pharmacology. 2026;183(15):4344-4363. doi:10.1111/bph.70458
BibTeX
@article{Singh2026,
author = {Singh, Aditya K and Haghighijoo, Zahra and Gurtu, Akanksha and Dvorak, Nolan M and Baumgartner, Timothy J and Goode, Nana A and Singh, Jully and Bernabucci, Matteo and Szafran, Adam T and Bolt, Michael J and Mancini, Michael A and Dvorak, Natalie M and Lijffijt, Marijn and Liu, Zhiqing and Xue, Yu and Thomas, Alyssa K and Villasante-Tezanos, Alejandro and Krishnan, Balaji and Zhou, Jia and Laezza, Fernanda},
title = {Targeting the noncatalytic activity of GSK3β modulates neuronal excitability in medium spiny neurons via Nav1.6 interactions},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {15},
pages = {4344--4363},
doi = {10.1111/bph.70458}
}
EUVIMED